Nikhil Prasad Fact checked by:Thailand Medical News Team Nov 17, 2026 17 minutes ago
As of mid-November 2026, Mexico continues to register ongoing COVID-19 circulation, with cumulative cases for the year remaining relatively low compared with earlier pandemic peaks but showing steady accumulation and the recent detection of a new recombinant variant. Health authorities are closely watching trends as the winter respiratory season intensifies.
COVID-19 Infections once again rising across Mexico
According to recent
Medical News and official epidemiological updates released in early November 2026, Mexico has confirmed approximately 3,050 to 3,105 COVID-19 cases and between 120 and 123 deaths from January through the first week of November. These figures come from the Secretaría de Salud’s weekly viral respiratory disease reports, including data for epidemiological week 44 (November 1–7, 2026). While daily numbers are modest, the cumulative totals and the timing of new detections have prompted renewed attention.
Case Distribution in November 2026
Mexico City continues to lead with the highest share of confirmed cases, followed by the State of Mexico, Puebla, Hidalgo, and Nuevo León. These five entities account for a significant portion of the year’s positives. Overall positivity among people tested for respiratory symptoms has stayed in the low single digits for most of 2026, though earlier mid-year elevations were recorded. The virus remains present in all 32 states, underscoring that transmission has not stopped even as severe outcomes stay limited.
Hospital burden remains manageable, reflecting widespread population immunity from previous infections and vaccinations. Still, health officials note that colder weather, increased indoor gatherings, and holiday travel in the coming weeks could support further spread.
Detection of the XFG “Frankenstein” Variant
Genomic surveillance has confirmed the presence of the XFG recombinant lineage, popularly nicknamed the “Frankenstein” variant because it combines genetic elements from Omicron sublineages LF.7 and LP.8.1.2. Circulation in Mexico was first widely reported in late October 2026, with continued detections into November. Available clinical data indicate it is more transmissible than some earlier strains but does not appear to cause more severe disease or higher mortality. Reported symptoms often include intense sore throat and hoarseness or temporary voice loss. Existing COVID-19 vaccines are expected to retain effectiveness against severe illness, hospitalization, and death.
Public Health Outlook for Late 2026
Mexican health authorities and regional bodies continue to treat COVID-19 as an endemic respiratory virus with periodic fluctuations rather than a high-emergency threat. Officials have previously flagged November and December as periods of elevated risk due to seasonal patterns. Basic precautions—staying up to date with recommended boosters where advised, improving ventilation, practicing hand hygiene, and isolating when symptomatic—remain the primary tools for reducing transmission, especially among older adults and people with underlying health conditions.For t
he most current figures, readers can consult the Secretaría de Salud’s weekly respiratory virus reports and established news coverage of the data. The situation in November 2026 illustrates that while COVID-19 no longer dominates public life, it has not disappeared and still requires monitoring as winter progresses.
References:
https://www.gob.mx/cms/uploads/attachment/file/1116393/Informe_semanal_ERV_SE44_2026_09.11.2026_.pdf
https://www.unotv.com/salud/que-es-xfg-la-variante-frankenstein-de-covid-19-con-su-presencia-en-mexicoque-es-xfg-la-variante-frankenstein-de-covid-19-con-presencia-en-mexico/
https://cadenapolitica.com/2026/11/11/mexico-registra-120-muertes-por-covid-19-en-2026/
https://www.gob.mx/salud/documentos/informes-semanales-para-la-vigilancia-epidemiologica-de-influenza-covid-19-y-otros-virus-respiratorios-2026
Read Also:
https://www.thailandmedical.news/articles/coronavirus